Aaron Wealth Advisors LLC lowered its stake in shares of McKesson Co. (NYSE:MCK – Free Report) by 7.3% during the third quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The fund owned 4,049 shares of the company’s stock after selling 318 shares during the quarter. Aaron Wealth Advisors LLC’s holdings in McKesson were worth $2,002,000 as of its most recent SEC filing.
A number of other hedge funds have also recently added to or reduced their stakes in MCK. Swedbank AB bought a new stake in McKesson during the 1st quarter worth about $669,326,000. Bessemer Group Inc. lifted its position in McKesson by 3,621.7% during the 1st quarter. Bessemer Group Inc. now owns 349,395 shares of the company’s stock valued at $187,572,000 after purchasing an additional 340,007 shares during the period. Bristol Gate Capital Partners Inc. acquired a new position in McKesson during the 1st quarter valued at about $97,510,000. American Century Companies Inc. lifted its position in McKesson by 134.6% during the 2nd quarter. American Century Companies Inc. now owns 220,619 shares of the company’s stock valued at $128,850,000 after purchasing an additional 126,567 shares during the period. Finally, Castle Hook Partners LP acquired a new position in McKesson during the 1st quarter valued at about $63,774,000. Institutional investors own 85.07% of the company’s stock.
Analyst Ratings Changes
A number of research firms have issued reports on MCK. Deutsche Bank Aktiengesellschaft cut their target price on shares of McKesson from $623.00 to $579.00 and set a “buy” rating on the stock in a research report on Wednesday, September 25th. Wells Fargo & Company cut their target price on shares of McKesson from $576.00 to $535.00 and set an “equal weight” rating on the stock in a research report on Friday, September 13th. Citigroup cut their target price on shares of McKesson from $670.00 to $630.00 and set a “buy” rating on the stock in a research report on Tuesday, September 10th. Leerink Partners cut their target price on shares of McKesson from $665.00 to $630.00 and set an “outperform” rating on the stock in a research report on Monday, October 7th. Finally, Argus increased their price target on shares of McKesson from $570.00 to $670.00 and gave the company a “buy” rating in a research report on Monday, June 24th. Five analysts have rated the stock with a hold rating and twelve have assigned a buy rating to the company’s stock. Based on data from MarketBeat.com, the company has an average rating of “Moderate Buy” and a consensus target price of $610.86.
Insider Transactions at McKesson
In other news, CEO Brian S. Tyler sold 3,753 shares of the firm’s stock in a transaction that occurred on Monday, August 5th. The shares were sold at an average price of $626.03, for a total transaction of $2,349,490.59. Following the completion of the transaction, the chief executive officer now directly owns 82,339 shares of the company’s stock, valued at $51,546,684.17. This trade represents a 0.00 % decrease in their position. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available through the SEC website. Company insiders own 0.11% of the company’s stock.
McKesson Stock Performance
MCK stock traded down $1.53 during mid-day trading on Friday, hitting $507.19. 170,377 shares of the company were exchanged, compared to its average volume of 804,397. The firm has a market cap of $65.90 billion, a P/E ratio of 22.73, a P/E/G ratio of 1.17 and a beta of 0.44. The firm’s 50 day simple moving average is $521.73 and its 200 day simple moving average is $552.12. McKesson Co. has a 1-year low of $431.35 and a 1-year high of $637.51.
McKesson (NYSE:MCK – Get Free Report) last announced its earnings results on Wednesday, August 7th. The company reported $7.88 EPS for the quarter, topping the consensus estimate of $7.21 by $0.67. The firm had revenue of $79.28 billion for the quarter, compared to the consensus estimate of $82.53 billion. McKesson had a net margin of 0.94% and a negative return on equity of 242.57%. The business’s quarterly revenue was up 6.4% on a year-over-year basis. During the same period last year, the company posted $7.27 EPS. On average, equities research analysts predict that McKesson Co. will post 32.07 EPS for the current fiscal year.
McKesson Increases Dividend
The firm also recently declared a quarterly dividend, which was paid on Tuesday, October 1st. Stockholders of record on Monday, September 2nd were paid a dividend of $0.71 per share. This is a boost from McKesson’s previous quarterly dividend of $0.62. This represents a $2.84 annualized dividend and a dividend yield of 0.56%. The ex-dividend date was Friday, August 30th. McKesson’s dividend payout ratio (DPR) is currently 12.69%.
About McKesson
McKesson Corporation provides healthcare services in the United States and internationally. It operates through four segments: U.S. Pharmaceutical, Prescription Technology Solutions (RxTS), Medical-Surgical Solutions, and International. The U.S. Pharmaceutical segment distributes branded, generic, specialty, biosimilar and over-the-counter pharmaceutical drugs, and other healthcare-related products.
Featured Articles
- Five stocks we like better than McKesson
- Natural Gas Prices Continue To Rally, These Stocks Should Benefit
- Analysts See Growth in CrowdStrike Stock Despite July Setback
- 3 Ways To Invest In Coffee, Other Than Drinking It
- The Uptrend in Netflix Will Continue: Another 15% Upside Ahead
- What is a Low P/E Ratio and What Does it Tell Investors?
- Buy the Dip? UiPath Stock’s GenAI Strategy May Pay Off
Want to see what other hedge funds are holding MCK? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for McKesson Co. (NYSE:MCK – Free Report).
Receive News & Ratings for McKesson Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for McKesson and related companies with MarketBeat.com's FREE daily email newsletter.